Dr Amy Holmes is an early career researcher and has a broad research interest in advancing the dermatological sciences. She was awarded her PhD in biomedical engineering from the Institute of Science and Technology in Medicine at Keele University (UK). Upon completion of her thesis she worked with industry at Dermal Technology Laboratory under Professor John Heylings. She is currently a postdoctoral researcher at the Therapeutics Research Centre at UniSA, South Australia, and is based at the Basil Hetzel Institute for Translational Medicine. Dr Amy Holmes is interested in developing topical and transdermal drug delivery systems, investigating the potential toxicity of dermally applied compounds, particularly nanomaterials, through percutaneous absorption studies using human skin.